Gene Patents Get Supreme Decision
Last week's U.S. Supreme Court decision on Myriad's breast cancer gene patents sparked many comments from patients, the public and scientists. Here's what several Johns Hopkins experts had to say about the topic: "I am thrilled with the Supreme Court's unanimous decision to overturn gene patents. This was the only choice and will open up […]